MX352660B - Bebida con contenido de citrato. - Google Patents
Bebida con contenido de citrato.Info
- Publication number
- MX352660B MX352660B MX2015013221A MX2015013221A MX352660B MX 352660 B MX352660 B MX 352660B MX 2015013221 A MX2015013221 A MX 2015013221A MX 2015013221 A MX2015013221 A MX 2015013221A MX 352660 B MX352660 B MX 352660B
- Authority
- MX
- Mexico
- Prior art keywords
- beverage compositions
- containing beverage
- citrate containing
- urine
- beverage
- Prior art date
Links
- 235000013361 beverage Nutrition 0.000 title abstract 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 4
- 210000002700 urine Anatomy 0.000 abstract 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Non-Alcoholic Beverages (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361793442P | 2013-03-15 | 2013-03-15 | |
| PCT/US2014/027736 WO2014152789A1 (en) | 2013-03-15 | 2014-03-14 | Citrate containing beverage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015013221A MX2015013221A (es) | 2016-04-15 |
| MX352660B true MX352660B (es) | 2017-12-04 |
Family
ID=51528113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015013221A MX352660B (es) | 2013-03-15 | 2014-03-14 | Bebida con contenido de citrato. |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US9278112B2 (enExample) |
| EP (1) | EP2983783B1 (enExample) |
| JP (1) | JP6581564B2 (enExample) |
| CN (1) | CN105209120A (enExample) |
| AU (1) | AU2014236553B2 (enExample) |
| BR (1) | BR112015023495A8 (enExample) |
| CA (1) | CA2906907C (enExample) |
| HK (1) | HK1219070A1 (enExample) |
| MX (1) | MX352660B (enExample) |
| PH (1) | PH12015502150A1 (enExample) |
| WO (1) | WO2014152789A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9278112B2 (en) * | 2013-03-15 | 2016-03-08 | New York University | Citrate containing beverage |
| US11273140B2 (en) * | 2013-06-06 | 2022-03-15 | Stefanie A. Seixas-Mikelus | Juice beverage for prevention and treatment of renal stones |
| ES2486441B1 (es) * | 2014-04-02 | 2015-06-11 | Universitat De Les Illes Balears | Preparaciones combinadas de acidificantes urinarios e inhibidores de la cristalización y su aplicación para el tratamiento o prevención de la litiasis renal fosfática o inducida por fosfato cálcico |
| WO2016159897A1 (en) * | 2015-04-01 | 2016-10-06 | Ay Doğan | Potassium citrate suspension |
| US20170035800A1 (en) * | 2015-08-06 | 2017-02-09 | Kenneth Davin Fine | Reduction of Oxalate Absorption in Individuals |
| JP6714984B2 (ja) * | 2015-08-31 | 2020-07-01 | キリンビバレッジ株式会社 | クエン酸由来の異味が低減された容器詰めクエン酸高含有酸性飲料 |
| WO2018080986A1 (en) | 2016-10-27 | 2018-05-03 | Seixas Mikelus Stefanie A | Juice beverage for prevention and treatment of renal stones |
| CN108125232A (zh) * | 2017-03-07 | 2018-06-08 | 浙江欣诺医药有限公司 | 预防与治疗泌尿系结石的补充剂及其制备方法和应用 |
| US10986857B2 (en) | 2017-08-22 | 2021-04-27 | LithoLyte Corporation | Dietary supplementation with mixed alkali salts |
| US11259553B2 (en) | 2017-08-22 | 2022-03-01 | Litholyte Corporation, Llc | Dietary supplementation with mixed alkali salts |
| CN108887682A (zh) * | 2018-06-09 | 2018-11-27 | 夏志君 | 柠檬酸钠制成柠檬酸钠养生粉及其应用 |
| KR20230005819A (ko) * | 2020-04-14 | 2023-01-10 | 닛뽕 케미파 가부시키가이샤 | 수면의 질의 개선제 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU165181B (enExample) * | 1971-11-08 | 1974-07-27 | ||
| US4966776A (en) | 1983-04-11 | 1990-10-30 | Board Of Regents, The University Of Texas System | Compositions and methods of treating calcium renal stones |
| CN1033349A (zh) * | 1987-11-28 | 1989-06-14 | 王龙祥 | 可乐系列饮料的制法 |
| US4985593A (en) | 1988-01-05 | 1991-01-15 | Mission Pharmacal Company, Inc. | Magnesium potassium citrate |
| US5108767A (en) * | 1991-06-10 | 1992-04-28 | Abbott Laboratories | Liquid nutritional product for persons receiving renal dialysis |
| US5085883A (en) * | 1991-06-27 | 1992-02-04 | Abbott Laboratories | Blend of dietary fiber for nutritional products |
| US5438042B1 (en) * | 1993-10-08 | 1997-08-26 | Sandoz Nutrition Ltd | Enteral nutritional composition having amino acid profile |
| US20010002269A1 (en) * | 1997-05-06 | 2001-05-31 | Zhao Iris Ginron | Multi-phase food & beverage |
| CN1438892A (zh) | 2000-06-02 | 2003-08-27 | 宝洁公司 | 低碳水化合物组合物、其套盒及其使用方法 |
| CN1284303A (zh) * | 2000-09-08 | 2001-02-21 | 徐华春 | 治疗结石的饮料 |
| US20030203072A1 (en) * | 2002-04-26 | 2003-10-30 | Team Nrg, Inc. | Rehydration beverage |
| US20050100637A1 (en) | 2003-11-12 | 2005-05-12 | Robert Murray | Carbohydrate and electrolyte replacement composition |
| US7323201B2 (en) | 2004-06-08 | 2008-01-29 | Tate & Lyle Ingredients Americas, Inc. | Highly soluble form of tricalcium citrate, and methods of its making and use |
| US20050276839A1 (en) * | 2004-06-10 | 2005-12-15 | Rifkin Calman H | Appetite satiation and hydration beverage |
| US7897192B2 (en) | 2004-10-07 | 2011-03-01 | Next Proteins, Inc. | High energy carbonated protein drink and method of making |
| US7205018B2 (en) | 2004-10-07 | 2007-04-17 | Next Proteins, Inc. | Carbonated protein drink and method of making |
| US20070077314A1 (en) | 2005-07-15 | 2007-04-05 | Pak Charles Y C | Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis |
| JP5349744B2 (ja) * | 2005-12-19 | 2013-11-20 | 松谷化学工業株式会社 | ミネラル吸収促進剤、食品及び飼料 |
| MY150223A (en) * | 2007-05-18 | 2013-12-31 | Mjn Us Holdings Llc | Acidified liquid human milk supplement |
| GB201012539D0 (en) * | 2010-07-27 | 2010-09-08 | Savantium Ltd | Nutritional compositions |
| WO2012068431A1 (en) | 2010-11-18 | 2012-05-24 | The Coca-Cola Company | Performance enhancing sports beverage and methods of use |
| US9278112B2 (en) * | 2013-03-15 | 2016-03-08 | New York University | Citrate containing beverage |
-
2014
- 2014-03-14 US US14/211,645 patent/US9278112B2/en active Active
- 2014-03-14 MX MX2015013221A patent/MX352660B/es active IP Right Grant
- 2014-03-14 JP JP2016502531A patent/JP6581564B2/ja active Active
- 2014-03-14 HK HK16107014.9A patent/HK1219070A1/zh unknown
- 2014-03-14 WO PCT/US2014/027736 patent/WO2014152789A1/en not_active Ceased
- 2014-03-14 CN CN201480027995.9A patent/CN105209120A/zh active Pending
- 2014-03-14 AU AU2014236553A patent/AU2014236553B2/en active Active
- 2014-03-14 EP EP14770577.6A patent/EP2983783B1/en active Active
- 2014-03-14 CA CA2906907A patent/CA2906907C/en active Active
- 2014-03-14 BR BR112015023495A patent/BR112015023495A8/pt not_active Application Discontinuation
-
2015
- 2015-09-15 PH PH12015502150A patent/PH12015502150A1/en unknown
-
2016
- 2016-03-07 US US15/062,509 patent/US9737564B2/en active Active
-
2017
- 2017-08-21 US US15/681,703 patent/US9895396B2/en active Active
-
2018
- 2018-02-15 US US15/897,344 patent/US10258645B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014236553B2 (en) | 2019-01-17 |
| US9737564B2 (en) | 2017-08-22 |
| JP2016513474A (ja) | 2016-05-16 |
| US20140271929A1 (en) | 2014-09-18 |
| US20180169144A1 (en) | 2018-06-21 |
| EP2983783A1 (en) | 2016-02-17 |
| BR112015023495A2 (pt) | 2017-07-18 |
| US20160184349A1 (en) | 2016-06-30 |
| EP2983783A4 (en) | 2016-10-26 |
| US10258645B2 (en) | 2019-04-16 |
| WO2014152789A1 (en) | 2014-09-25 |
| CN105209120A (zh) | 2015-12-30 |
| JP6581564B2 (ja) | 2019-09-25 |
| PH12015502150A1 (en) | 2016-01-25 |
| US20170340664A1 (en) | 2017-11-30 |
| HK1219070A1 (zh) | 2017-03-24 |
| EP2983783B1 (en) | 2021-04-21 |
| US9895396B2 (en) | 2018-02-20 |
| CA2906907C (en) | 2021-04-13 |
| MX2015013221A (es) | 2016-04-15 |
| BR112015023495A8 (pt) | 2019-12-03 |
| US9278112B2 (en) | 2016-03-08 |
| AU2014236553A1 (en) | 2015-11-05 |
| CA2906907A1 (en) | 2014-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015502150A1 (en) | Citrate containing beverage | |
| DK3349763T3 (en) | Composition for use in microbiota modulation | |
| EP3054940A4 (en) | Compositions and methods for treating non-alcoholic steatohepatitis | |
| SG11201507288UA (en) | Compositions and methods for treating non-alcoholic steatohepatitis | |
| PH12015502659A1 (en) | Surface treatment compositions comprising photochromic dyes | |
| EP3054953A4 (en) | Hdac inhibitors, alone or in combination with pi3k inhibitors, for treating non-hodgkin's lymphoma | |
| IL241191B (en) | Local compositions and kits that include them for the treatment of local disorders | |
| IL259836B (en) | Dimeric macrocyclic cations, complexes containing them and their uses as contrast agents | |
| HK1214510A1 (zh) | 用於癌症治疗的gla单一疗法 | |
| IL241823B (en) | Preparations containing novyi .c and their uses for the treatment of cancerous tumors | |
| MX2016004802A (es) | Anticuerpos anti-r-espondina (anti-rspo) y metodos de uso. | |
| EP3055377A4 (en) | Wet-process ceria compositions for selectively polishing substrates, and methods related thereto | |
| MX2015009818A (es) | Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerosis multiple. | |
| WO2015179598A3 (en) | Systems and methods for exchange of buffer solutions | |
| PL3458448T3 (pl) | Inhibitory fasn do zastosowania w leczeniu niealkoholowego stłuszczeniowego zapalenia wątroby | |
| EP3031245A4 (en) | Bs and ue, and interference cancellation methods used in the same | |
| ZA201506330B (en) | Methods and compositions for treating leukemia | |
| MX2015010023A (es) | Anticuerpos anti-cd83 y su uso. | |
| PT3076834T (pt) | Máquina de preparação de bebidas e método de funcionamento de uma máquina de preparação de bebidas | |
| EP3234927A4 (en) | Taximeter for use in vehicles and method for the same | |
| EP3290918A4 (en) | Immunochromatography device having reduced background noises, and method for reducing background noises in immunochromatographty device | |
| GB201421661D0 (en) | Method for determining the concentration of iron ions in hydrocarbon compositions | |
| WO2014160628A3 (en) | Articles and methods for preventing and treating dermatologic adverse events | |
| MX2017008612A (es) | Películas envolventes con opacidad aumentada. | |
| EP3249987A4 (en) | Method and device for use in enhancing carrier aggregation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |